HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 04, April 2018 – Digestive health in the 21st century - Trust your guts       » Food wasted in China could feed 30-50 million       » Chinese scientists analyze human brain's "CPU"       » $150,000 fundraiser launched to sequence South Asian genomes       » Green tea-based drug carriers improve cancer treatment       » Scientists grow liver cancer cells in lab      
EYE ON CHINA For e-subscribers (PDF)
Vol 22, No 01, January 2018
Scientists close in on origin of SARS

Researchers believe deadly virus began in bats in Yunnan province

Chinese Academy of Sciences sets up innovation center in Bangkok

CAS Innovation Cooperation Center (Bangkok) to promote scientific and technological cooperation between China, Thailand and ASEAN.

Chinese researchers map key protein in DNA repair with near-atomic resolution

Provides a molecular blueprint for the development of novel ATR inhibitors as potential cancer therapeutic agents.

AstraZeneca to develop new drugs with Chinese partner

The new company holds exclusive rights to develop and commercialise three potential medicines currently in pre-clinical development from AstraZeneca's pipeline in its main therapy areas of oncology, cardiovascular and metabolic diseases, and respiratory.

European medical training facility opens China office

Aims to assist the development of China's medical education sector

China's biotech industry output to exceed 1.21 trillion dollars by 2020

This will account for over 4 percent of China's GDP by 2020.

Chinese-made ventricular assist device enters clinical testing

VAD is known globally as one of the most effective measures to treat patients with severe heart failure and testing will be conducted in three hospitals.

Novogen to establish China entity to further commercialisation and partnerships in China

Following initial face-to-face discussions with third parties in China, Novogen has signed Letter of Intent with Cedrus Investments, a leading specialist investment bank based in Hong Kong, for advisory services in order to establish a corporate structure and operations in the People's Republic of China.

Eisai's Aricept approved for additional indication of severe Alzheimer's disease in China

Aricept is the first Alzheimer's disease treatment with a broad indication that covers mild to severe Alzheimer's disease in China.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy